Partner Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Partner Therapeutics is a mid-sized biotechnology company focused on developing and commercializing cancer medicines and combination therapies intended to improve patient outcomes. The organization centers its work on patients, aiming to support treatment decisions and the cancer journey, while pursuing a multi-disciplinary, team-based approach to therapy development. It collaborates with leading companies, researchers, physicians, and patient advocates to test products in appropriate settings and combinations, and to ensure information is accessible to care teams and patients.

Based in Lexington, Massachusetts, it operates in the biotechnology research sector and emphasizes real-world patient outcomes as a key measure of impact. In December 2024, Partner Therapeutics signed an exclusive license with Merus for the commercialization of zenocutuzumab-zbco (Zeno) for NRG1-positive non-small cell lung cancer and pancreatic cancer.

Sign up for free to view info

Company overview Employee directory